BRONCHOLYTE

This brand name is authorized in Nigeria.

Active ingredients

The drug BRONCHOLYTE contains one active pharmaceutical ingredient (API):

1	Bromhexine UNII YC2ZOM3Z8V - BROMHEXINE HYDROCHLORIDE
	Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”.
	Read more about Bromhexine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2904	Syrup	Broncholyte Elixir SYRUP 4 mg/5 mL 100ML	9 Broncholyte Elixir Broncholyte Bromhexine Hydrochloride Mucolytic agent Bromhexine Hydrochloride 4mg/5ml Elixir x 100mls Treatment of chronic inflammatory pulmonary conditions, bronchitis with broncho spasm and asthma OTC Sygen Pharmaceuticals Ltd. Km 38, Lagos-Abeokuta Expressway, Sango-Ota, Ogun State, Nigeria same as applicant same as applicant 04-2904	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CB02	Bromhexine	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2904